Open Access policy in pharmaceuticals

Open Access policy in pharmaceuticals refers to the practice of making research data, clinical trial results, and scientific information freely available to the public. This approach promotes transparency, collaboration, and accelerated innovation by allowing researchers, healthcare professionals, and the public to access vital information without restrictions. It aims to improve understanding of medicines, support evidence-based decisions, and ensure that new treatments can be developed and evaluated more efficiently, ultimately benefiting patient care and public health.